person · Reporting owner

Bardwell Kathleen

Disclosed activity across 5 companies

Tapewire entity: 66464
SEC CIK: 0001532367

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
STERIS plcSTE · Entity 3228	Sr.V. P. & C.C.O.	June 28, 2019	July 02, 2019
Varex Imaging CorpVREX · Entity 5135	Director	February 12, 2026	February 13, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

STERIS plc

Report date June 28, 2019 · Filed July 02, 2019

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	24,428	Reported balance After 2019-06-28 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2019-06-28 · Exercise / conversion · Acquired 7,000 · Balance 24,428 F1: This Exercise and sale of a total of 7,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F2: This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.
Ordinary SharesSEC Table I · non-derivative	Direct	17,428	Reported balance After 2019-06-28 transaction · row 2 Account or security details depend on footnotes; rows are not merged. 1 source row Row 2 · 2019-06-28 · Sale · Disposed 7,000 · Balance 17,428 F1: This Exercise and sale of a total of 7,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F3: Price reflects a weighted average sale price for multiple transactions ranging from $147.00 to $147.24 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F4: 3,646 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 148 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021; 148 on June 1, 2021; 393 on May 31, 2022; 148 on May 31, 2022 and 148 on May 31, 2023.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.52 · Expires 2024-05-30	Direct	0	Reported balance After 2019-06-28 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-06-28 · Exercise / conversion · Disposed 7,000 · Balance 0 F2: This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.

Filing footnotes · ownership attribution and instrument terms

F1: This Exercise and sale of a total of 7,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019.

F2: This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.

F3: Price reflects a weighted average sale price for multiple transactions ranging from $147.00 to $147.24 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F4: 3,646 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 148 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021; 148 on June 1, 2021; 393 on May 31, 2022; 148 on May 31, 2022 and 148 on May 31, 2023.

Varex Imaging Corp

Report date February 12, 2026 · Filed February 13, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Deferred Stock UnitsSEC Table II · derivative / convertible security	Direct	12,331	Reported balance After 2026-02-12 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-02-12 · Grant · Acquired 12,331 · Balance 12,331 F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

Filing footnotes · ownership attribution and instrument terms

F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

FIRST FINANCIAL BANCORP /OH/

Report date May 26, 2020 · Filed May 27, 2020

Section 16 reporting ended · disclosed 2020-05-27. Current position is not established by this disclosure.

No balance rows disclosed in this filing.

MAINSOURCE FINANCIAL GROUP

Report date April 01, 2018 · Filed April 03, 2018

Section 16 reporting ended · disclosed 2018-04-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2018-04-01 transaction · row 1 1 source row Row 1 · 2018-04-01 · Disposition to issuer · Disposed 16,712 · Balance 0 F1: On April 1, 2018, MainSource completed its previously announced merger (the "Merger") with First Financial Bancorp, pursuant to an Agreement and Plan of Merger, dated as of July 25, 2017, between MainSource and First Financial. In accordance with the terms of the Merger Agreement, at the effective time of the Merger each share of MainSource common stock issued an outstanding immediately prior to the Merger was converted into the right to receive 1.3875 shares of common stock of First Financial Bancorp. A cash payment of equal value was made in lieu of the issuance of fractional share

Filing footnotes · ownership attribution and instrument terms

F1: On April 1, 2018, MainSource completed its previously announced merger (the "Merger") with First Financial Bancorp, pursuant to an Agreement and Plan of Merger, dated as of July 25, 2017, between MainSource and First Financial. In accordance with the terms of the Merger Agreement, at the effective time of the Merger each share of MainSource common stock issued an outstanding immediately prior to the Merger was converted into the right to receive 1.3875 shares of common stock of First Financial Bancorp. A cash payment of equal value was made in lieu of the issuance of fractional share

STERIS plc

Report date March 28, 2019 · Filed March 28, 2019

Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Ordinary Shares, 10 pence par valueSEC Table I · non-derivative	Direct	Reported balance After 2019-03-28 transaction · row 1 1 source row Row 1 · 2019-03-28 · Disposition to issuer · Disposed 17,441 · Balance 0 F1: 5,072 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 625 on May 28, 2019; 500 on May 30, 2019; 393 on May 31, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021 and 393 on May 31, 2022. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.34 · Expires 2023-05-31	Direct	Reported balance After 2019-03-28 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2019-03-28 · Disposition to issuer · Disposed 5,360 · Balance 0 F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 5,360 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.52 · Expires 2024-05-30	Direct	Reported balance After 2019-03-28 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-03-28 · Disposition to issuer · Disposed 7,000 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.98 · Expires 2025-08-10	Direct	Reported balance After 2019-03-28 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2019-03-28 · Disposition to issuer · Disposed 10,000 · Balance 0 F5: This option becomes exercisable as follows: 2,500 on May 28, 2016; 2,500 on May 28, 2017; 2,500 on May 28, 2018; and 2,500 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 10,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.72 · Expires 2026-06-01	Direct	Reported balance After 2019-03-28 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2019-03-28 · Disposition to issuer · Disposed 7,000 · Balance 0 F6: This option becomes exercisable as follows: 1,750 on June 1, 2017; 1,750 on June 1, 2018; 1,750 on June 3, 2019 and 1,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.07 · Expires 2027-05-30	Direct	Reported balance After 2019-03-28 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2019-03-28 · Disposition to issuer · Disposed 10,000 · Balance 0 F7: This option becomes exercisable as follows: 2,500 on May 30, 2018; 2,500 on May 30, 2019; 2,500 on June 1, 2020 and 2,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 10,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.22 · Expires 2028-05-31	Direct	Reported balance After 2019-03-28 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2019-03-28 · Disposition to issuer · Disposed 9,332 · Balance 0 F8: This option becomes exercisable as follows: 2,333 on May 31, 2019; 2,333 on June 1, 2020; 2,333 on June 1, 2021 and 2,333 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 9,332 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

Filing footnotes · ownership attribution and instrument terms

F1: 5,072 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 625 on May 28, 2019; 500 on May 30, 2019; 393 on May 31, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021 and 393 on May 31, 2022.

F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.

F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 5,360 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F5: This option becomes exercisable as follows: 2,500 on May 28, 2016; 2,500 on May 28, 2017; 2,500 on May 28, 2018; and 2,500 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 10,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F6: This option becomes exercisable as follows: 1,750 on June 1, 2017; 1,750 on June 1, 2018; 1,750 on June 3, 2019 and 1,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F7: This option becomes exercisable as follows: 2,500 on May 30, 2018; 2,500 on May 30, 2019; 2,500 on June 1, 2020 and 2,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 10,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option

F8: This option becomes exercisable as follows: 2,333 on May 31, 2019; 2,333 on June 1, 2020; 2,333 on June 1, 2021 and 2,333 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 9,332 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
February 12, 2026 Filed Feb 13, 2026 16:08 UTC	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	12,331	$0.00	$0.00	Disclosure SEC source: 0001681622-26-000029 · wk-form4_1771016891.xml · derivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,331 Underlying: Common Stock · 12,331 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document
February 09, 2026 Filed Feb 9, 2026 16:14 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionDeferred Stock Units · Derivative	8,483	$0.00	$0.00	Disclosure SEC source: 0001532367-26-000002 · wk-form4_1770671647.xml · derivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. F2 · derivative.expiration_date: These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant. Read SEC document
February 09, 2026 Filed Feb 9, 2026 16:14 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	8,483	Not disclosed	Not disclosed	Disclosure SEC source: 0001532367-26-000002 · wk-form4_1770671647.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 13, 2025 Filed Feb 14, 2025 19:04 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionDeferred Stock Units · Derivative	3,619	$0.00	$0.00	Disclosure SEC source: 0001681622-25-000027 · wk-form4_1739577854.xml · derivative · entry 3 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,619 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units were issued on August 18, 2022, vested on February 9, 2023, and delivery of the vested Deferred Stock Units, in the form of common stock, occurred on February 13, 2025, the date of the Issuer's 2025 Annual Meeting. F3 · derivative.expiration_date: These Deferred Stock Units were issued on August 18, 2022, vested on February 9, 2023, and delivery of the vested Deferred Stock Units, in the form of common stock, occurred on February 13, 2025, the date of the Issuer's 2025 Annual Meeting. Read SEC document
February 13, 2025 Filed Feb 14, 2025 19:04 UTC	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	12,123	$0.00	$0.00	Disclosure SEC source: 0001681622-25-000027 · wk-form4_1739577854.xml · derivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,123 Underlying: Common Stock · 12,123 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document
February 13, 2025 Filed Feb 14, 2025 19:04 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	3,619	Not disclosed	Not disclosed	Disclosure SEC source: 0001681622-25-000027 · wk-form4_1739577854.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 08, 2024 Filed Feb 12, 2024 17:04 UTC	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	9,643	$0.00	$0.00	Disclosure SEC source: 0001681622-24-000025 · wk-form4_1707775464.xml · derivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,643 Underlying: Common Stock · 9,643 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document
February 09, 2023 Filed Feb 13, 2023 17:26 UTC	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	8,483	$0.00	$0.00	Disclosure SEC source: 0001681622-23-000028 · wf-form4_167632718472322.xml · derivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,483 Underlying: Common Stock · 8,483 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document
August 18, 2022 Filed Aug 22, 2022 17:05 UTC	Varex Imaging Corp VREX · Entity 5135	GrantDeferred Stock Units · Derivative	3,619	$0.00	$0.00	Disclosure SEC source: 0001681622-22-000080 · wf-form4_166120230561881.xml · derivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,619 Underlying: Common Stock · 3,619 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest in full on the date of the next annual meeting (February 9, 2023) subject to the reporting person serving on the board of the company through the vesting date. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 annual meeting (ii) a change in control, (iii) the non-employee director termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest in full on the date of the next annual meeting (February 9, 2023) subject to the reporting person serving on the board of the company through the vesting date. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 annual meeting (ii) a change in control, (iii) the non-employee director termination of service for any reason. Read SEC document
June 28, 2019 Filed Jul 2, 2019 20:30 UTC	STERIS plc STE · Entity 3228	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	7,000	$0.00 Strike: $53.52	$0.00	Disclosure SEC source: 0001209191-19-040302 · doc4.xml · derivative · entry 3 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,000 shares Expires 2024-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document
June 28, 2019 Filed Jul 2, 2019 20:30 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	7,000	$147.07	$1,029,490.00	Disclosure SEC source: 0001209191-19-040302 · doc4.xml · nonDerivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,428 F1 · shares: This Exercise and sale of a total of 7,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $147.00 to $147.24 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F4 · balance_after: 3,646 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 148 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021; 148 on June 1, 2021; 393 on May 31, 2022; 148 on May 31, 2022 and 148 on May 31, 2023. Read SEC document
June 28, 2019 Filed Jul 2, 2019 20:30 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	7,000	$53.52	$374,640.00	Disclosure SEC source: 0001209191-19-040302 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Exercise and sale of a total of 7,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F2 · shares: This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document
June 19, 2019 Filed Jun 21, 2019 20:27 UTC	STERIS plc STE · Entity 3228	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	5,360	$0.00 Strike: $45.34	$0.00	Disclosure SEC source: 0001209191-19-038467 · doc4.xml · derivative · entry 3 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,360 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 5,360 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 5,360 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document
June 19, 2019 Filed Jun 21, 2019 20:27 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	5,360	$145.05	$777,468.00	Disclosure SEC source: 0001209191-19-038467 · doc4.xml · nonDerivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,428 F1 · shares: This Exercise and sale of a total of 5,360 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $145.00 to $145.12 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: 3,646 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 148 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021; 148 on June 1, 2021; 393 on May 31, 2022; 148 on May 31, 2022 and 148 on May 31, 2023. Read SEC document
June 19, 2019 Filed Jun 21, 2019 20:27 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	5,360	$45.34	$243,022.40	Disclosure SEC source: 0001209191-19-038467 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Exercise and sale of a total of 5,360 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F2 · shares: This option to purchase 5,360 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 5,360 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. F3 · balance_after: 3,646 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 148 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021; 148 on June 1, 2021; 393 on May 31, 2022; 148 on May 31, 2022 and 148 on May 31, 2023. Read SEC document
June 03, 2019 Filed Jun 5, 2019 20:30 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	150	$134.07	$20,110.50	Disclosure SEC source: 0001209191-19-034745 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,428 F1 · shares: 150 shares were withheld from the 500 restricted shares that vested on June 3, 2019. These 150 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 500 ordinary shares were awarded to Ms. Bardwell on June 1, 2016 as part of an award of 2,000 restricted shares. These vested shares were valued at the NYSE closing market price on June 3, 2019. The remaining restrictions on these ordinary shares lapse as follows: 500 on June 1, 2020. F2 · balance_after: 3,646 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 148 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021; 148 on June 1, 2021; 393 on May 31, 2022; 148 on May 31, 2022 and 148 on May 31, 2023. Read SEC document
May 31, 2019 Filed Jun 3, 2019 20:33 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	3,420	Not disclosed Strike: $147.05	Not disclosed	Disclosure SEC source: 0001209191-19-033929 · doc4.xml · derivative · entry 4 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,420 Underlying: Ordinary Shares · 3,420 shares Expires 2029-05-31 F5 · price: This option becomes exercisable as follows: 855 on June 1, 2020; 855 on June 1, 2021; 855 on May 31, 2022 and 855 on May 31, 2023. F5 · derivative.exercise_date: This option becomes exercisable as follows: 855 on June 1, 2020; 855 on June 1, 2021; 855 on May 31, 2022 and 855 on May 31, 2023. Read SEC document
May 31, 2019 Filed Jun 3, 2019 20:33 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	592	$0.00	$0.00	Disclosure SEC source: 0001209191-19-033929 · doc4.xml · nonDerivative · entry 3 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,578 F3 · shares: All 592 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 148 on June 1, 2020; 148 on June 1, 2021; 148 on May 31, 2022 and 148 on May 31, 2023. F4 · balance_after: 4,146 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 148 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021; 148 on June 1, 2021; 393 on May 31, 2022; 148 on May 31, 2022 and 148 on May 31, 2023. Read SEC document
May 31, 2019 Filed Jun 3, 2019 20:33 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	118	$133.68	$15,774.24	Disclosure SEC source: 0001209191-19-033929 · doc4.xml · nonDerivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,986 F2 · shares: 118 shares were withheld from the 393 restricted shares that vested on May 31, 2019. These 118 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 393 ordinary shares were awarded to Ms. Bardwell on May 31, 2018 as part of an award of 1,572 restricted shares. These vested shares were valued at the NYSE closing market price on May 31, 2019. The remaining restrictions on these ordinary shares lapse as follows: 393 on June 1, 2020; 393 on June 1, 2021 and 393 on May 31, 2022. Read SEC document
May 30, 2019 Filed Jun 3, 2019 20:33 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	150	$133.35	$20,002.50	Disclosure SEC source: 0001209191-19-033929 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,104 F1 · shares: 150 shares were withheld from the 500 restricted shares that vested on May 30, 2019. These 150 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 500 ordinary shares were awarded to Ms. Bardwell on May 30, 2017 as part of an award of 2,000 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2019. The remaining restrictions on these ordinary shares lapse as follows: 500 on May 30, 2020 and 500 on May 30, 2021. Read SEC document
May 28, 2019 Filed May 29, 2019 20:12 UTC	FIRST FINANCIAL BANCORP /OH/ FFBC · Entity 2057	GrantCommon Stock	2,163	$0.00	$0.00	Disclosure SEC source: 0001127602-19-020133 · form4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,305 Read SEC document
May 28, 2019 Filed May 30, 2019 20:26 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	187	$133.92	$25,043.04	Disclosure SEC source: 0001209191-19-033432 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,254 F1 · shares: 187 shares were withheld from the 625 restricted shares that vested on May 28, 2019. These 187 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 625 ordinary shares were awarded to Ms. Bardwell on August 10, 2015 as part of an award of 2,500 restricted shares. These vested shares were valued at the NYSE closing market price on May 28, 2019. F2 · balance_after: 4,447 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 500 on May 30, 2019; 393 on May 31, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021 and 393 on May 31, 2022. Read SEC document
March 28, 2019 Filed Mar 28, 2019 18:55 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	9,332	Not disclosed Strike: $114.22	Not disclosed	Disclosure SEC source: 0001209191-19-021595 · doc4.xml · derivative · entry 7 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,332 Underlying: Ordinary Shares · 9,332 shares Expires 2028-05-31 F8 · price: This option becomes exercisable as follows: 2,333 on May 31, 2019; 2,333 on June 1, 2020; 2,333 on June 1, 2021 and 2,333 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 9,332 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. F8 · derivative.exercise_date: This option becomes exercisable as follows: 2,333 on May 31, 2019; 2,333 on June 1, 2020; 2,333 on June 1, 2021 and 2,333 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 9,332 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 18:55 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	10,000	Not disclosed Strike: $77.07	Not disclosed	Disclosure SEC source: 0001209191-19-021595 · doc4.xml · derivative · entry 6 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2027-05-30 F7 · price: This option becomes exercisable as follows: 2,500 on May 30, 2018; 2,500 on May 30, 2019; 2,500 on June 1, 2020 and 2,500 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 10,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. F7 · derivative.exercise_date: This option becomes exercisable as follows: 2,500 on May 30, 2018; 2,500 on May 30, 2019; 2,500 on June 1, 2020 and 2,500 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 10,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 18:55 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	7,000	Not disclosed Strike: $69.72	Not disclosed	Disclosure SEC source: 0001209191-19-021595 · doc4.xml · derivative · entry 5 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Ordinary Shares · 7,000 shares Expires 2026-06-01 F6 · price: This option becomes exercisable as follows: 1,750 on June 1, 2017; 1,750 on June 1, 2018; 1,750 on June 3, 2019 and 1,750 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 7,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 1,750 on June 1, 2017; 1,750 on June 1, 2018; 1,750 on June 3, 2019 and 1,750 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 7,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 18:55 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	10,000	Not disclosed Strike: $67.98	Not disclosed	Disclosure SEC source: 0001209191-19-021595 · doc4.xml · derivative · entry 4 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2025-08-10 F5 · price: This option becomes exercisable as follows: 2,500 on May 28, 2016; 2,500 on May 28, 2017; 2,500 on May 28, 2018 and 2,500 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 10,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option becomes exercisable as follows: 2,500 on May 28, 2016; 2,500 on May 28, 2017; 2,500 on May 28, 2018 and 2,500 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 10,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 18:55 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	7,000	Not disclosed Strike: $53.52	Not disclosed	Disclosure SEC source: 0001209191-19-021595 · doc4.xml · derivative · entry 3 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Ordinary Shares · 7,000 shares Expires 2024-05-30 F4 · price: This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option F4 · derivative.exercise_date: This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option Read SEC document
March 28, 2019 Filed Mar 28, 2019 18:55 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	5,360	Not disclosed Strike: $45.34	Not disclosed	Disclosure SEC source: 0001209191-19-021595 · doc4.xml · derivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,360 Underlying: Ordinary Shares · 5,360 shares Expires 2023-05-31 F3 · price: This option to purchase 5,360 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 5,360 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option to purchase 5,360 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 5,360 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 18:55 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	17,441	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-021595 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,441 F1 · shares: 5,072 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 625 on May 28, 2019; 500 on May 30, 2019; 393 on May 31, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021 and 393 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F1 · balance_after: 5,072 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 625 on May 28, 2019; 500 on May 30, 2019; 393 on May 31, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021 and 393 on May 31, 2022. Read SEC document
March 28, 2019 Filed Mar 28, 2019 09:34 UTC	STERIS plc STE · Entity 158792	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	9,332	Not disclosed Strike: $114.22	Not disclosed	Disclosure SEC source: 0001209191-19-021553 · doc4.xml · derivative · entry 7 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,332 shares Expires 2028-05-31 F8 · price: This option becomes exercisable as follows: 2,333 on May 31, 2019; 2,333 on June 1, 2020; 2,333 on June 1, 2021 and 2,333 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 9,332 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F8 · derivative.exercise_date: This option becomes exercisable as follows: 2,333 on May 31, 2019; 2,333 on June 1, 2020; 2,333 on June 1, 2021 and 2,333 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 9,332 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 09:34 UTC	STERIS plc STE · Entity 158792	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	10,000	Not disclosed Strike: $77.07	Not disclosed	Disclosure SEC source: 0001209191-19-021553 · doc4.xml · derivative · entry 6 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,000 shares Expires 2027-05-30 F7 · price: This option becomes exercisable as follows: 2,500 on May 30, 2018; 2,500 on May 30, 2019; 2,500 on June 1, 2020 and 2,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 10,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option F7 · derivative.exercise_date: This option becomes exercisable as follows: 2,500 on May 30, 2018; 2,500 on May 30, 2019; 2,500 on June 1, 2020 and 2,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 10,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option Read SEC document
March 28, 2019 Filed Mar 28, 2019 09:34 UTC	STERIS plc STE · Entity 158792	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	7,000	Not disclosed Strike: $69.72	Not disclosed	Disclosure SEC source: 0001209191-19-021553 · doc4.xml · derivative · entry 5 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,000 shares Expires 2026-06-01 F6 · price: This option becomes exercisable as follows: 1,750 on June 1, 2017; 1,750 on June 1, 2018; 1,750 on June 3, 2019 and 1,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 1,750 on June 1, 2017; 1,750 on June 1, 2018; 1,750 on June 3, 2019 and 1,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 09:34 UTC	STERIS plc STE · Entity 158792	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	10,000	Not disclosed Strike: $67.98	Not disclosed	Disclosure SEC source: 0001209191-19-021553 · doc4.xml · derivative · entry 4 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,000 shares Expires 2025-08-10 F5 · price: This option becomes exercisable as follows: 2,500 on May 28, 2016; 2,500 on May 28, 2017; 2,500 on May 28, 2018; and 2,500 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 10,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F5 · derivative.exercise_date: This option becomes exercisable as follows: 2,500 on May 28, 2016; 2,500 on May 28, 2017; 2,500 on May 28, 2018; and 2,500 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 10,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 09:34 UTC	STERIS plc STE · Entity 158792	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	7,000	Not disclosed Strike: $53.52	Not disclosed	Disclosure SEC source: 0001209191-19-021553 · doc4.xml · derivative · entry 3 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,000 shares Expires 2024-05-30 F4 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F4 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 09:34 UTC	STERIS plc STE · Entity 158792	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	5,360	Not disclosed Strike: $45.34	Not disclosed	Disclosure SEC source: 0001209191-19-021553 · doc4.xml · derivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,360 shares Expires 2023-05-31 F3 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 5,360 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F3 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 5,360 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document
March 28, 2019 Filed Mar 28, 2019 09:34 UTC	STERIS plc STE · Entity 158792	Disposition to issuerOrdinary Shares, 10 pence par value	17,441	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-021553 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: 5,072 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 625 on May 28, 2019; 500 on May 30, 2019; 393 on May 31, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021 and 393 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Read SEC document
October 11, 2018 Filed Oct 12, 2018 12:35 UTC	FIRST FINANCIAL BANCORP /OH/ FFBC · Entity 2057	PurchaseCommon Stock	214	$28.92	$6,188.82	Disclosure SEC source: 0001127602-18-030047 · form4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,142 Read SEC document
October 01, 2018 Filed Oct 3, 2018 16:32 UTC	STERIS plc STE · Entity 158792	Tax withholdingOrdinary Shares, 10 pence par value	112	$114.16	$12,785.92	Disclosure SEC source: 0001209191-18-053818 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,441 F1 · shares: 112 shares were withheld from the 375 restricted shares that vested on October 1, 2018. These 112 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 375 ordinary shares were awarded to Ms. Bardwell on June 1, 2016 as part of an award of 1,500 restricted shares. These vested shares were valued at the NYSE closing market price on October 1, 2018. F2 · balance_after: 5,072 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 625 on May 28, 2019; 500 on May 30, 2019; 393 on May 31, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021 and 393 on May 31, 2022. Read SEC document
July 10, 2018 Filed Jul 11, 2018 18:16 UTC	FIRST FINANCIAL BANCORP /OH/ FFBC · Entity 2057	PurchaseCommon Stock	193	$31.80	$6,137.36	Disclosure SEC source: 0001127602-18-023098 · form4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,928 Read SEC document
June 01, 2018 Filed Jun 4, 2018 16:36 UTC	STERIS plc STE · Entity 158792	Tax withholdingOrdinary Shares, 10 pence par value	150	$104.57	$15,685.50	Disclosure SEC source: 0001209191-18-035128 · doc4.xml · nonDerivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,553 F2 · shares: 150 shares were withheld from the 500 restricted shares that vested on June 1, 2018. These 150 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 500 ordinary shares were awarded to Ms. Bardwell on June 1, 2016 as part of an award of 2,000 restricted shares. These vested shares were valued at the NYSE closing market price on June 1, 2017. The remaining restrictions on these ordinary shares lapse as follows: 500 on June 3, 2019 and 500 on June 1, 2020. F3 · balance_after: 5,447 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 375 on October 1, 2018; 625 on May 28, 2019; 500 on May 30, 2019; 393 on May 31, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021 and 393 on May 31, 2022. Read SEC document
May 31, 2018 Filed Jun 4, 2018 16:36 UTC	STERIS plc STE · Entity 158792	GrantEmployee Stock Option (right to buy) · Derivative	9,332	$0.00 Strike: $114.22	$0.00	Disclosure SEC source: 0001209191-18-035128 · doc4.xml · derivative · entry 3 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,332 Underlying: Ordinary Shares · 9,332 shares Expires 2028-05-31 F4 · derivative.exercise_date: This option becomes exercisable as follows: 2,333 on May 31, 2019; 2,333 on June 1, 2020; 2,333 on June 1, 2021 and 2,333 on May 31, 2022. Read SEC document
May 31, 2018 Filed Jun 4, 2018 16:36 UTC	STERIS plc STE · Entity 158792	GrantOrdinary Shares, 10 pence par value	1,572	$0.00	$0.00	Disclosure SEC source: 0001209191-18-035128 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,703 F1 · shares: All 1,572 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 393 on May 31, 2019; 393 on June 1, 2020; 393 on June 1, 2021 and 393 on May 31, 2022. Read SEC document
May 30, 2018 Filed May 31, 2018 17:09 UTC	STERIS plc STE · Entity 158792	Tax withholdingOrdinary Shares, 10 pence par value	150	$104.57	$15,685.50	Disclosure SEC source: 0001209191-18-034405 · doc4.xml · nonDerivative · entry 3 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,131 F3 · shares: 150 shares were withheld from the 500 restricted shares that vested on May 30, 2018. These 150 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 500 ordinary shares were awarded to Ms. Bardwell on May 30, 2017 as part of an award of 2,000 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2018. The remaining restrictions on these ordinary shares lapse as follows: 500 on May 30, 2019; 500 on May 30, 2020 and 500 on May 30, 2021. F4 · balance_after: 4,375 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 500 on June 1, 2018; 375 on October 1, 2018; 625 on May 28, 2019; 500 on May 30, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020 and 500 on June 1, 2021. Read SEC document
May 30, 2018 Filed May 31, 2018 17:09 UTC	STERIS plc STE · Entity 158792	Tax withholdingOrdinary Shares, 10 pence par value	224	$104.57	$23,423.68	Disclosure SEC source: 0001209191-18-034405 · doc4.xml · nonDerivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,281 F2 · shares: 224 shares were withheld from the 750 restricted shares that vested on May 30, 2018. These 224 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 750 ordinary shares were awarded to Ms. Bardwell on May 30, 2014 as part of an award of 3,000 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2018. Read SEC document
May 29, 2018 Filed May 31, 2018 17:09 UTC	STERIS plc STE · Entity 158792	Tax withholdingOrdinary Shares, 10 pence par value	181	$103.97	$18,818.57	Disclosure SEC source: 0001209191-18-034405 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,505 F1 · shares: 181 shares were withheld from the 625 restricted shares that vested on May 29, 2018. These 181 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 625 ordinary shares were awarded to Ms. Bardwell on August 10, 2015 as part of an award of 2,500 restricted shares. These vested shares were valued at the NYSE closing market price on May 29, 2018. The remaining restrictions on these ordinary shares lapse as follows: 625 on May 28, 2019. Read SEC document
May 22, 2018 Filed May 24, 2018 20:25 UTC	FIRST FINANCIAL BANCORP /OH/ FFBC · Entity 2057	GrantCommon Stock	1,548	$0.00	$0.00	Disclosure SEC source: 0001127602-18-018758 · form4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,735 Read SEC document
April 01, 2018 Filed Apr 3, 2018 16:23 UTC	MAINSOURCE FINANCIAL GROUP MSFG · Entity 167861	Disposition to issuerCommon Stock	16,712	Not disclosed	Not disclosed	Disclosure SEC source: 0001179110-18-005225 · edgar.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: On April 1, 2018, MainSource completed its previously announced merger (the "Merger") with First Financial Bancorp, pursuant to an Agreement and Plan of Merger, dated as of July 25, 2017, between MainSource and First Financial. In accordance with the terms of the Merger Agreement, at the effective time of the Merger each share of MainSource common stock issued an outstanding immediately prior to the Merger was converted into the right to receive 1.3875 shares of common stock of First Financial Bancorp. A cash payment of equal value was made in lieu of the issuance of fractional share Read SEC document
April 01, 2018 Filed Apr 3, 2018 23:19 UTC	FIRST FINANCIAL BANCORP /OH/ FFBC · Entity 2057	GrantCommon Stock	23,187	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-18-013872 · form4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,187 F1 · price: Received pursuant to the merger agreement between First Financial Bancorp. ("First Financial") and MainSource Financial Group, Inc. ("MainSource"), dated July 25, 2017 (the "Merger Agreement"), pursuant to which MainSource was merged with and into First Financial on April 1, 2018 (the "Effective Time"). Pursuant to the Merger Agreement, as of the Effective Time, (i) each issued and outstanding share of MainSource's common stock converted into the right to receive 1.3875 shares of First Financial common stock and cash in lieu of fractional shares (the "Merger Consideration"), and (ii) each outstanding restricted share and each outstanding performance share unit fully vested and was cancelled and converted automatically into the right to receive the Merger Consideration in respect of each share of MainSource's common stock underlying such award, less applicable tax withholdings. On the trading day immediately preceding Effective Date, the closing price of MainSource's common stock was $40.65 per share and the closing price of First Financial's common stock was $29.35 per share. Read SEC document
October 02, 2017 Filed Oct 3, 2017 16:40 UTC	STERIS plc STE · Entity 158792	Tax withholdingOrdinary Shares, 10 pence par value	124	$88.80	$11,011.20	Disclosure SEC source: 0001209191-17-055172 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,686 F1 · shares: 124 shares were withheld from the 375 restricted shares that vested on October 2, 2017. These 124 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 375 ordinary shares were awarded to Ms. Bardwell on June 1, 2016 as part of an award of 1,500 restricted shares. These vested shares were valued at the NYSE closing market price on October 2, 2017. F2 · balance_after: 6,250 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 625 on May 28, 2018; 500 on May 30, 2018; 750 on May 30, 2018; 500 on June 1, 2018; 375 on October 1, 2018; 625 on May 28, 2019; 500 on May 30, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020 and 500 on June 1, 2021. Read SEC document
June 16, 2017 Filed Jun 19, 2017 16:46 UTC	STERIS plc STE · Entity 158792	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	3,795	$0.00 Strike: $29.94	$0.00	Disclosure SEC source: 0001209191-17-040862 · doc4.xml · derivative · entry 3 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,795 shares Expires 2022-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of a total of 3,795 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 15, 2016. F3 · derivative.exercise_date: This option to purchase 3,795 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 3,795 STERIS Corporation common shares for $29.94 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.